CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on November 19, 2008
Clin J Am Soc Nephrol 4: 186-194, 2009
© 2009 American Society of Nephrology
doi: 10.2215/CJN.03050608

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.03050608v1
4/1/186    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muntner, P.
Right arrow Articles by Leonard, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muntner, P.
Right arrow Articles by Leonard, M. B.

Mineral Metabolism and Bone Disease

Association of Serum Intact Parathyroid Hormone with Lower Estimated Glomerular Filtration Rate

Paul Muntner*, Tiffany M. Jones{dagger}, Amanda D. Hyre{ddagger}, Michal L. Melamed§, Arnold Alper{dagger}, Paolo Raggi, and Mary B. Leonard{ddagger},||

* Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York; {dagger} Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana; {ddagger} Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; § Departments of Medicine and Epidemiology & Population Health, Albert Einstein College of Medicine, New York, New York; Department of Medicine, Emory University, Atlanta, Georgia; and || Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Correspondence: Dr. Paul Muntner, Department of Community and Preventive Medicine, Mount Sinai School of Medicine, 1 Gustave L Levy Place, Box 1057, New York, NY 10016; Phone: (212) 824-7024; Fax: (212) 996-0407; E-mail: paul.muntner{at}mssm.edu

Background and objectives: The prevalence of mineral metabolism abnormalities is almost universal in stage 5 chronic kidney disease (CKD), but the presence of abnormalities in milder CKD is not well characterized.

Design, setting, participants, & measurements: Data on adults ≥20 yr of age from the National Health and Nutrition Examination Survey 2003–2004 (N = 3949) were analyzed to determine the association between moderate declines in estimated GFR (eGFR), calculated using the Modfication of Diet in Renal Disease formula, and serum intact parathyroid hormone (iPTH) ≥ 70 pg/ml.

Results: The geometric mean iPTH level was 39.3 pg/ml. The age-standardized prevalence of elevated iPTH was 8.2%, 19.3%, and 38.3% for participants with eGFR ≥ 60, 45 to 59, and 30 to 44 ml/min/1.73 m2, respectively (P-trend < 0.001). After adjustment for age; race/ethnicity; sex; menopausal status; education; income; cigarette smoking; alcohol consumption; body mass index; hypertension; diabetes mellitus; vitamin D supplement use; total calorie and calcium intake; and serum calcium, phosphorus, and 25-hydroxyvitamin D levels—and compared with their counterparts with an eGFR ≥ 60 ml/min/1.73 m2—the prevalence ratios of elevated iPTH were 2.30 and 4.69 for participants with an eGFR of 45 to 59 and 30 to 44 ml/min/1.73 m2, respectively (P-trend < 0.001). Serum phosphorus ≥ 4.2 mg/dl and 25-hydroxyvitamin D < 17.6 ng/ml were more common at lower eGFR levels. No association was present between lower eGFR and serum calcium < 9.4 mg/dl.

Conclusions: This study indicates that elevated iPTH levels are common among patients with moderate CKD.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society of Nephrology.